A three-year project to develop new strategies for tackling resistance to antibiotics will start in 2026, GSK Plc announced on 18 November. The project will receive £45 million from GSK to execute six projects which have been identified by Imperial College London and Imperial College Healthcare NHS Trust, leaders of the Fleming Initiative in the UK. The funding will support an estimated 50 UK scientific and academic jobs focusing exclusively on antimicrobial resistance.
